. Merck & Co., USA

The award will be collected by Dr. Kevin Ali, President (Emerging Markets) on behalf of the company.

The organizing committee of BioAsia 2012 takes pride in bestowing the Genome Valley Excellence Award 2012 on Merck & Co., USA in light of –

• Merck's commitment to Patient Health & vaccine research
• Vision, cutting-edge research and continual leadership status in the biopharmaceutical space, particularly vaccines.
• Its support and backing to the initiatives focused on preventing female cancers